Smad3-Targeted Therapy Protects against Cisplatin-Induced AKI by Attenuating Programmed Cell Death and Inflammation via a NOX4-Dependent Mechanism.
Kidney Dis (Basel)
; 7(5): 372-390, 2021 Sep.
Article
en En
| MEDLINE
| ID: mdl-34604344
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Guideline
/
Prognostic_studies
Idioma:
En
Revista:
Kidney Dis (Basel)
Año:
2021
Tipo del documento:
Article